{
    "2021-11-20": [
        [
            {
                "time": "2023-10-18",
                "original_text": "DICERNA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Dicerna Pharmaceuticals, Inc. - DRNA",
                "features": {
                    "keywords": [
                        "DICERNA",
                        "Investor Alert",
                        "Former Attorney General",
                        "Kahn Swick & Foti",
                        "Adequacy of Price",
                        "Proposed Sale",
                        "Dicerna Pharmaceuticals"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}